Patient-specific redox profiling may guide personalized treatment selection while hybrid multifunctional nanoplatforms integrating therapy, imaging, and GSH modulation can enhance therapeutic precision
The medication is indicated for weight loss, type 2 diabetes and improving metabolic health in obese and overweight patients with other weight-related health conditions
Nanoparticles were designed with a 2,2-(propane-2,2-diylbis(sulfanediyl)) bis(ethan-1-ol) linker that could be oxidized by ROS, decompose into oligomeric units, and release the ruthenium catalyst
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper peptide found in human plasma, saliva, and urine
For questions about sourcing research peptides from a reputable supplier, see our guide to choosing a research peptide supplier and our best peptide companies 2026 review